EQUITY (Details Narrative) - USD ($)		9 Months Ended	12 Months Ended
	Feb. 10, 2018	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Feb. 16, 2022	Jan. 03, 2022
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Stock Split Terms			All common stock numbers and exercise prices in this Note are reflected on a post reverse split (5 to 1) basis. As a result of the reverse split on February 9, 2018
Additional shares issued due to rounding	167
Options re-issued to directors			15,900,000
Exercise price			$ 0.05
Option expense			$ 821,995	$ 109,874
Risk free interest			1.37%
Dividend yield			0.00%
Volatility			142.00%
Market price			$ 0.05
Active directors options						300,000
Recorded options expense			$ 31,807
Options expected life			5 years
Number of Options repriced					900,000
Number of shares issued				297,673
Value of shares issued				$ 70,810
Loss on shares issued				$ 8,685
Officer [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Options re-issued to directors			900,000
Officer options granted		15,000,000
Exercise price			$ 0.07
Years for options			3 years
Option expense			$ 751,744
Risk free interest			1.35%
Dividend yield			0.00%
Volatility			174.00%
Market price			$ 0.07
Option expected life			3 years
Director [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Exercise price			$ 0.08
Option expense			$ 38,444
Risk free interest			1.90%
Dividend yield			0.00%
Volatility			153.00%
Market price			$ 0.08
Options expected life			5 years
[custom:DirectorsTermsExtension]			5 years